United States Securities and Exchange Commission · EDGAR
Accession 0002087846-26-000002
Form C
-TR
Termination of Reporting — Regulation Crowdfunding
Issuer CIK
2087846
Vertical Longevity Pharmaceuticals, Inc.
Corporation
DE
Incorporated 2025
IRVINE, CA
vertical-longevity-pharma.com
Reporting
terminated